Quantum Biopharma (QNTM) EV to CFO (2020 - 2026)
Quantum Biopharma's (QNTM) quarterly EV to CFO came in at 4.79 in Q2 2026, up 52.88% year-over-year from 3.13 in Q2 2025, and up 35.66% quarter-over-quarter from 7.44 in Q1 2026.
Powered by 
Analysis
Quantum Biopharma (QNTM) EV to CFO (2020 - 2026) Analysis & Trends
Quantum Biopharma has disclosed EV to CFO across 7 years of filings, most recently posting 4.79 for Q2 2026.
- In Q2 2026, EV to CFO rose 52.88% year-over-year to 4.79; the TTM figure through Jun 2026 stood at 1.56 (up 17.12% YoY), while the FY2025 annual figure was 2.99, down 821.56% from the prior year.
- EV to CFO came in at 4.79 for Q2 2026 at Quantum Biopharma, up from 7.44 in the prior quarter.
- In the past five years, EV to CFO ranged from a high of 380.59 in Q1 2022 to a low of 818.87 in Q1 2023.
- Average EV to CFO over 5 years is 106.02, with a median of 9.29 recorded in 2025.
- Year-over-year, EV to CFO surged 99.87% in 2025 and slumped 684.24% in 2026.
- Over 5 years, EV to CFO stood at 39.07 in 2022, then sank by 322.18% to 164.95 in 2023, then jumped by 84.17% to 26.11 in 2024, then jumped by 67.77% to 8.41 in 2025, then jumped by 43.08% to 4.79 in 2026.
- Per Business Quant data, the three most recent EV to CFO figures were 4.79 in Q2 2026, 7.44 in Q1 2026, and 8.41 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Quantum Biopharma | 12.60 Mn | 7.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.79 |
| Mar 31, 2026 | -7.44 |
| Sep 30, 2025 | -8.41 |
| Jun 30, 2025 | -10.16 |
| Mar 31, 2025 | -0.95 |
| Sep 30, 2024 | -26.11 |
| Jun 30, 2024 | -512.96 |
| Mar 31, 2024 | -704.93 |
| Dec 31, 2023 | -164.95 |
| Mar 31, 2023 | -818.87 |
| Dec 31, 2022 | -39.07 |
| Sep 30, 2022 | 246.14 |
| Jun 30, 2022 | 187.57 |
| Mar 31, 2022 | 380.59 |
| Dec 31, 2021 | -61.00 |
| Sep 30, 2021 | 261.08 |
| Jun 30, 2021 | 200.33 |
| Mar 31, 2021 | 263.54 |
| Dec 31, 2020 | 35.94 |
| Sep 30, 2020 | -153.32 |